Abstract:
A robot control apparatus and a method of controlling a robot are provided. The robot control apparatus includes an approval unit assigning a basic parameter required for communication including identification of each robot in order to prepare for communication when the robot is connected, a contents file acquisition unit acquiring a contents file including one or more contents for which each one has an execution subject and an execution time predetermined, and a contents file interpretation unit interpreting the contents file and transferring the contents to be executed at a predetermined time to the corresponding execution subject, so as to synchronously execute contents in two or more robots.
Abstract:
A robot server for controlling a robot, a system for providing content having the same, and a method thereof are provided. The robot server communicating with the robot includes a virtual robot object and a virtual robot object manager. The robot server executes commands that are generated in correspondence to the robot and received from the robot, and controls the robot. The virtual robot object manager generates the virtual robot object corresponding to the robot and activates the virtual robot object when connected to the robot.
Abstract:
The present invention relates to a Dual Interface IC card including a top layer, a bottom layer, an antenna embedding layer between the top and bottom layers and an IC chip module embedded in an IC chip module embedding hole. The antenna embedding layer has a groove in a rectangular shape at its one side where elastic plates are embedded in both sides of the groove. The IC chip module is inserted by applying an adhesive onto the antenna embedding layer or using an adhesive tape. Thus, the IC chip module is easily installed and not detached to give a good connection and a long time use.
Abstract:
A class of 2′-fluoro-nucleoside compounds are disclosed which are useful in the treatment of hepatitis B infection, hepatitis C infection, HIV and abnormal cellular proliferation, including tumors and cancer. The compounds have the general formulae: wherein Base is a purine or pyrimidine base; R1 is OH, H, OR3, N3, CN, halogen, including F, or CF3, lower alkyl, amino, loweralkylamino, di(lower)alkylamino, or alkoxy, and base refers to a purine or pyrimidine base; R2 is H, phosphate, including monophosphate, diphosphate, triphosphate, or a stabilized phosphate prodrug; acyl, or other pharmaceutically acceptable leaving group which when administered in vivo, is capable of providing a compound wherein R2 is H or phosphate; sulfonate ester including alkyl or arylalkyl sulfonyl including methanesulfonyl, benzyl, wherein the phenyl group is optionally substituted with one or more substituents as described in the definition of aryl given above, a lipid, an amino acid, peptide, or cholesterol; and R3 is acyl, alkyl, phosphate, or other pharmaceutically acceptable leaving group which when administered in vivo, is capable of being cleaved to the parent compound, or a pharmaceutically acceptable salt thereof.
Abstract translation:公开了一类可用于治疗乙型肝炎感染,丙型肝炎感染,HIV和异常细胞增殖(包括肿瘤和癌症)的2'-氟 - 核苷化合物。 所述化合物具有以下通式:其中碱是嘌呤或嘧啶碱; R 1是OH,H,OR 3,N 3,CN,卤素,包括F或CF 3 N ,低级烷基,氨基,低级烷基氨基,二(低级)烷基氨基或烷氧基,碱是指嘌呤或嘧啶碱基; R 2是H,磷酸盐,包括单磷酸盐,二磷酸盐,三磷酸盐或稳定化的磷酸盐前药; 酰基或其它药学上可接受的离去基团,其当在体内施用时能够提供其中R 2是H或磷酸酯的化合物; 磺酸酯,包括烷基或芳基烷基磺酰基,包括甲磺酰基,苄基,其中苯基任选被一个或多个取代基取代,如上述芳基定义中所述,脂质,氨基酸,肽或胆固醇; 并且R 3是酰基,烷基,磷酸酯或其它药学上可接受的离去基团,当其在体内施用时,其能够被切割成母体化合物或其药学上可接受的盐。
Abstract:
The present invention relates to a description and implementation method of ThreadBean in an Enterprise Java Bean (EJB) container. In the description and implementation method of ThreadBean in an EJB (Enterprise Java Bean) container, the ThreadBean is defined using EJB to which an independent thread is allocated such that looping is performed while a message entering a determined message target is processed or a business logic periodically driven to perform a specific work is processed.
Abstract:
The present invention relates to a compound inhibiting HF-1 activity, a preparation method of the same, and a pharmaceutical composition comprising the same as an active ingredient. The compound of the present invention demonstrates anticancer activity not by non-selective cytotoxicity but by inhibiting the activity of HIF-1, the transcription factor playing an important role in cancer cell growth and metastasis.Accordingly, the compound or the pharmaceutically acceptable salt thereof according to the present invention inhibits HIF-1 activity, and therefore can be used as a therapeutic agent for solid tumors such as colon cancer, liver cancer, stomach cancer and breast cancer. In addition, the compound or the pharmaceutically acceptable salt thereof according to the present invention can be used as an active ingredient for a therapeutic agent for diabetic retinopathy or arthritis which may become worse when hypoxia-induced VEGF expression by HIF-1 increases.
Abstract:
The present invention relates to a novel biphenyl derivative or a pharmaceutically acceptable salt thereof, a pharmaceutical composition for preventing or treating inflammatory diseases or autoimmune diseases comprising the same as an active ingredient, and methods for treating inflammatory disease or autoimmune diseases with the pharmaceutical composition. Novel biphenyl derivatives according to the present invention promote the phagocytosis of macrophages and inhibit the chemotaxis to exhibit excellent inflammation terminating and anti-inflammatory effects and thus can be effectively used as therapeutic agents for inflammatory diseases or autoimmune diseases.
Abstract:
Provided are a novel derivative of 5-carbamoyl adamantan-2-yl amide of Formula (I), or a pharmaceutically acceptable salt thereof, and a pharmaceutical use thereof for inhibiting the activity of 11β-hydroxystreroid dehydrogenase type 1 (11b-HSD1) or for preventing and/or treating various diseases mediated by 11β-hydroxystreroid dehydrogenase type 1.
Abstract:
Provided are a novel derivative of 5-carbamoyl adamantan-2-yl amide or a pharmaceutically acceptable salt thereof, and a pharmaceutical use thereof for inhibiting the activity of 11β-hydroxystreroid dehydrogenase type 1 (11b-HSD1) or for preventing and/or treating various diseases mediated by 11β-hydroxystreroid dehydrogenase type 1.
Abstract:
A nozzle for a burner boom water spray system of an offshore plant that can more efficiently shield a high heat source generating when combusting gas generating upon drilling crude oil is provided. The nozzle includes: a front ejecting portion having a first nozzle tap at the center; a first side ejecting portion formed at a lower side of the front ejecting portion; a second side ejecting portion formed at a lower side of the first side ejecting portion; and a fastening portion formed at a lower side of the second side ejecting portion and coupled to a member for supplying a nozzle injection fluid. The nozzle provides a side ejecting portion of two stages in addition to a front ejecting portion, and thus an efficient water curtain pattern can be embodied.